Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrograde intrarenal stone surgery with isoprenaline irrigation for ESWL-resistant kidney stones
2005-005972-34Phase 2Completed
- Sponsor
- Fredericia Hospital
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of isoprenaline in nephrolithiasis, sponsored by Fredericia Hospital. Primary endpoint: Renal pelvic pressure reduction. Started Jan 2006; status: completed.
02
Drugs
isoprenaline
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on 2005-005972-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005972-34.